Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4
- PMID: 16479018
- DOI: 10.1194/jlr.M600027-JLR200
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4
Abstract
The LIPID MAPS Consortium (www.lipidmaps.org) is developing comprehensive procedures for identifying all lipids of the macrophage, following activation by endotoxin. The goal is to quantify temporal and spatial changes in lipids that occur with cellular metabolism and to develop bioinformatic approaches that establish dynamic lipid networks. To achieve these aims, an endotoxin of the highest possible analytical specification is crucial. We now report a large-scale preparation of 3-deoxy-D-manno-octulosonic acid (Kdo)(2)-Lipid A, a nearly homogeneous Re lipopolysaccharide (LPS) sub-structure with endotoxin activity equal to LPS. Kdo(2)-Lipid A was extracted from 2 kg cell paste of a heptose-deficient Escherichia coli mutant. It was purified by chromatography on silica, DEAE-cellulose, and C18 reverse-phase resin. Structure and purity were evaluated by electrospray ionization/mass spectrometry, liquid chromatography/mass spectrometry and (1)H-NMR. Its bioactivity was compared with LPS in RAW 264.7 cells and bone marrow macrophages from wild-type and toll-like receptor 4 (TLR-4)-deficient mice. Cytokine and eicosanoid production, in conjunction with gene expression profiling, were employed as readouts. Kdo(2)-Lipid A is comparable to LPS by these criteria. Its activity is reduced by >10(3) in cells from TLR-4-deficient mice. The purity of Kdo(2)-Lipid A should facilitate structural analysis of complexes with receptors like TLR-4/MD2.
Similar articles
-
A phosphoethanolamine transferase specific for the outer 3-deoxy-D-manno-octulosonic acid residue of Escherichia coli lipopolysaccharide. Identification of the eptB gene and Ca2+ hypersensitivity of an eptB deletion mutant.J Biol Chem. 2005 Jun 3;280(22):21202-11. doi: 10.1074/jbc.M500964200. Epub 2005 Mar 28. J Biol Chem. 2005. PMID: 15795227
-
Construction and characterization of an Escherichia coli mutant producing Kdo₂-lipid A.Mar Drugs. 2014 Mar 13;12(3):1495-511. doi: 10.3390/md12031495. Mar Drugs. 2014. PMID: 24633251 Free PMC article.
-
Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.Infect Immun. 2004 Jan;72(1):371-80. doi: 10.1128/IAI.72.1.371-380.2004. Infect Immun. 2004. PMID: 14688118 Free PMC article.
-
Structure and Effects of Cyanobacterial Lipopolysaccharides.Mar Drugs. 2015 Jul 7;13(7):4217-30. doi: 10.3390/md13074217. Mar Drugs. 2015. PMID: 26198237 Free PMC article. Review.
-
Kdo2 -lipid A: structural diversity and impact on immunopharmacology.Biol Rev Camb Philos Soc. 2015 May;90(2):408-27. doi: 10.1111/brv.12114. Epub 2014 May 16. Biol Rev Camb Philos Soc. 2015. PMID: 24838025 Free PMC article. Review.
Cited by
-
A nano-enhanced vaccine for metastatic melanoma immunotherapy.Cancer Drug Resist. 2022 Jul 7;5(3):829-845. doi: 10.20517/cdr.2021.132. eCollection 2022. Cancer Drug Resist. 2022. PMID: 36176766 Free PMC article.
-
Metabolic pathways in immune cell activation and quiescence.Immunity. 2013 Apr 18;38(4):633-43. doi: 10.1016/j.immuni.2013.04.005. Immunity. 2013. PMID: 23601682 Free PMC article. Review.
-
Lipid A modification systems in gram-negative bacteria.Annu Rev Biochem. 2007;76:295-329. doi: 10.1146/annurev.biochem.76.010307.145803. Annu Rev Biochem. 2007. PMID: 17362200 Free PMC article. Review.
-
Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease.Front Cardiovasc Med. 2018 Aug 3;5:97. doi: 10.3389/fcvm.2018.00097. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 30123798 Free PMC article. Review.
-
Towards mapping electrostatic interactions between Kdo2-lipid A and cationic antimicrobial peptides via ultraviolet photodissociation mass spectrometry.Analyst. 2018 Jul 23;143(15):3607-3618. doi: 10.1039/c8an00652k. Analyst. 2018. PMID: 29968868 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
